A phase I trial of iPSC-derived MSCs (CYP-001) in steroid-resistant acute GvHD
Affiliation
The Royal Marsden NHS Foundation Trust, LondonIssue Date
2018
Metadata
Show full item recordCitation
Bloor A, Patel A, Griffin J, Gilleece M, Radia R, Yeung D, et al. A phase I trial of iPSC-derived MSCs (CYP-001) in steroid-resistant acute GvHD. Blood. 2018;132.Journal
BloodDOI
10.1182/blood-2018-99-110432Additional Links
https://dx.doi.org/10.1182/blood-2018-99-110432Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1182/blood-2018-99-110432